INTERLEUKIN (IL)-6 AS A PANCREAS CARCINOMA-DERIVED VASCULAR-PERMEABILITY REGULATOR IN-VITRO

Citation
M. Omi et al., INTERLEUKIN (IL)-6 AS A PANCREAS CARCINOMA-DERIVED VASCULAR-PERMEABILITY REGULATOR IN-VITRO, Pathology research and practice, 192(11), 1996, pp. 1107-1112
Citations number
27
Categorie Soggetti
Pathology
ISSN journal
03440338
Volume
192
Issue
11
Year of publication
1996
Pages
1107 - 1112
Database
ISI
SICI code
0344-0338(1996)192:11<1107:I(AAPC>2.0.ZU;2-Q
Abstract
The interaction between pancreas adenocarcinoma and vascular endotheli al cells in vitro was investigated. Culture media of pancreas carcinom a cells PCI-10, but not PCI-24, induced an augmented albumin permeabil ity across the endothelial monolayer, an event which was blocked by th e calmodulin antagonist, W-7. Only marginal inhibitory effects were ob tained using protein kinase inhibitors, H-7 and HA-1004. When cytokine production by pancreas carcinoma cells was examined, production of IL -6 in large amounts by PCI-10, but not by PCI-24 cells was evident. As recombinant IL-6 generated a dose-dependent permeability increase, an d as this effect was inhibited by W-7, we considered that the enhancem ent of vascular permeability was mediated by this cytokine. The activi ty of culture supernatants for enhanced permeability was almost comple tely absorbed by the addition of an antibody specific for IL-6. Tumor- derived IL-6 as a soluble mediator regulates vascular permeability in vitro, and the production of this factor by pancreas adenocarcinoma ce lls presumably modulates biologic behavior.